AT239489T

Composition containing pyrrolizidine-alkaloid-free petasites

Abstract

Use of a pharmaceutical composition based on petasites extract without hepatotoxic effect, carcinogenic, cytostatic and / or mutagenic give the petasites extract of the plant and / or plant parts of the genus Petasites for the preparation of a medicament for the treatment pollinosis, eczemas and / or psoriasis, characterized in that the petasites extract is free of pyrrolizidine alkaloids, adding to the pharmaceutical composition given case magnesium and / or other pharmaceutically and / or physiologically active substances.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

14 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims8

Priority claims
DocumentOfficeKindDate
19838848GermanyA
19838848GermanyA
9904484European Patent Office (EPO)W
9904484European Patent Office (EPO)W
19838848
9904484
DE19981038848
WO1999EP04484

Members14

Family members, oldest first
DocumentOfficeKind
DE19838848A1GermanyA1
WO0012107A1World Intellectual Property Organization (WIPO)A1
AU4902299AAustraliaA
EP1107775A1European Patent Office (EPO)A1
JP2002523464AJapanA
US6551626B1United States of AmericaB1
EP1107775B1European Patent Office (EPO)B1
AT239489TThis recordAustriaT
ATE239489T1AustriaT1
DE59905484D1GermanyD1
US2004018251A1United States of AmericaA1
ES2198926T3SpainT3
US7090871B2United States of AmericaB2
EP1107775B2European Patent Office (EPO)B2